265 related articles for article (PubMed ID: 20845618)
21. Anaemia and heart failure: statement of the problem.
Lewis BS; Karkabi B; Jaffe R; Yuval R; Flugelman MY; Halon DA
Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii3-6. PubMed ID: 16024830
[TBL] [Abstract][Full Text] [Related]
22. Approaches to the treatment of anaemia in patients with chronic heart failure.
Murphy CL; McMurray JJ
Heart Fail Rev; 2008 Dec; 13(4):431-8. PubMed ID: 18392791
[TBL] [Abstract][Full Text] [Related]
23. The role of correction of anaemia in patients with congestive heart failure: a short review.
Silverberg DS; Wexler D; Iaina A; Schwartz D
Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380
[TBL] [Abstract][Full Text] [Related]
24. Anemia and chronic heart failure implications and treatment options.
Anand IS
J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
[TBL] [Abstract][Full Text] [Related]
25. Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.
Drug Ther Bull; 2004 Mar; 42(3):21-3. PubMed ID: 15038080
[TBL] [Abstract][Full Text] [Related]
26. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
27. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
van der Meer P; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787
[TBL] [Abstract][Full Text] [Related]
28. Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
Ghali JK; Anand IS; Abraham WT; Fonarow GC; Greenberg B; Krum H; Massie BM; Wasserman SM; Trotman ML; Sun Y; Knusel B; Armstrong P;
Circulation; 2008 Jan; 117(4):526-35. PubMed ID: 18195176
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of weekly darbepoetin alfa in the treatment of anaemia of HIV-infected haemodialysis patients.
Lucas C; Carrera F; Jorge C; Boquinhas H; Pais MJ
Nephrol Dial Transplant; 2006 Nov; 21(11):3202-6. PubMed ID: 16891651
[TBL] [Abstract][Full Text] [Related]
30. [Characteristics of anaemia treatment in children with chronic kidney disease].
Puretić Z
Acta Med Croatica; 2009 Sep; 63 Suppl 1():27-32. PubMed ID: 20235352
[TBL] [Abstract][Full Text] [Related]
31. Anemia in heart failure:current evidence and challenges.
Tang WH
Rev Cardiovasc Med; 2007; 8(2):78-86. PubMed ID: 17603426
[TBL] [Abstract][Full Text] [Related]
32. Anemia in chronic heart failure: etiology and treatment options.
Westenbrink BD; de Boer RA; Voors AA; van Gilst WH; van Veldhuisen DJ
Curr Opin Cardiol; 2008 Mar; 23(2):141-7. PubMed ID: 18303527
[TBL] [Abstract][Full Text] [Related]
33. Ferric carboxymaltose in patients with heart failure and iron deficiency.
Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
[TBL] [Abstract][Full Text] [Related]
34. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Skali H; Lin J; Pfeffer MA; Chen CY; Cooper ME; McMurray JJ; Nissenson AR; Remuzzi G; Rossert J; Parfrey PS; Scott-Douglas NW; Singh AK; Toto R; Uno H; Ivanovich P
Am J Kidney Dis; 2013 Feb; 61(2):238-46. PubMed ID: 23159232
[TBL] [Abstract][Full Text] [Related]
36. Anemia in chronic heart failure.
Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
[TBL] [Abstract][Full Text] [Related]
37. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B
Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
[TBL] [Abstract][Full Text] [Related]
38. Triumph and tragedy: anemia management in chronic kidney disease.
Novak JE; Szczech LA
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):580-8. PubMed ID: 18941350
[TBL] [Abstract][Full Text] [Related]
39. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
Trkulja V
Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
[TBL] [Abstract][Full Text] [Related]
40. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure.
Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D
Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
